3M Company vs Vir Biotechnology Inc. Common Stock — how do they compare? 3M Company trades at $164.2 (market cap $83.94B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: 3M Company is far larger — about 46.6× Vir Biotechnology Inc. Common Stock's market cap, and 3M Company pays a 1.92% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold 3M Company for 169 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| MMM | VIR | |
|---|---|---|
Market Cap | $83.94B | $1.80B |
Volume | 2,547,210 | 1,782,836 |
Sector | Industrials | Health |
52-Week High | $183.79 | $11.78 |
52-Week Low | $141.10 | $5.12 |
Typical Hold Time | 169 Days | 0 Days |
Enterprise Value | $93.17B | $1.36B |
Dividend Yield | 1.92% | — |
Signals from Pluang's Aura AI — not financial advice
3M (MMM) trades at $164.46, up 2.22% with strong recent earnings beats and a bullish analyst consensus price target of $191. The stock shows bearish technical signals but maintains solid fundamentals with 11.9% net margins and 82.77% ROE. Recent Q2 2026 results confirmed operational improvements with 5.4% organic growth and raised guidance, though technical indicators suggest near-term pressure.
The outlook remains positive with manageable litigation risks and strategic focus on high-growth areas like data centers. Key risks include consumer segment weakness and debt levels. Wall Street sentiment is balanced with 48% buy ratings, supporting potential upside from current levels despite technical bearishness.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →